0000899243-21-046120.txt : 20211124
0000899243-21-046120.hdr.sgml : 20211124
20211124210925
ACCESSION NUMBER: 0000899243-21-046120
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211111
FILED AS OF DATE: 20211124
DATE AS OF CHANGE: 20211124
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LaFrance Norman D.
CENTRAL INDEX KEY: 0001397768
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34375
FILM NUMBER: 211448928
MAIL ADDRESS:
STREET 1: MOLECULAR INSIGHT PHARMCEUTICALS, INC.
STREET 2: 160 SECOND STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PLUS THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001095981
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 330827593
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4200 MARATHON BLVD.
STREET 2: SUITE 200
CITY: AUSTIN
STATE: TX
ZIP: 78756
BUSINESS PHONE: 737.255.7194
MAIL ADDRESS:
STREET 1: 4200 MARATHON BLVD.
STREET 2: SUITE 200
CITY: AUSTIN
STATE: TX
ZIP: 78756
FORMER COMPANY:
FORMER CONFORMED NAME: CYTORI THERAPEUTICS, INC.
DATE OF NAME CHANGE: 20050712
FORMER COMPANY:
FORMER CONFORMED NAME: MACROPORE INC
DATE OF NAME CHANGE: 20010320
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-11-11
0
0001095981
PLUS THERAPEUTICS, INC.
PSTV
0001397768
LaFrance Norman D.
C/O PLUS THERAPEUTICS INC.
4200 MARATHON BOULEVARD, SUITE 200
AUSTIN
TX
78756
0
1
0
0
CHIEF MEDICAL OFFICER
Stock Option (right to buy shares of common stock)
120000.00
2021-11-01
4
A
0
120000
0.00
A
2031-11-11
Common Stock
120000
120000
D
25% of the options will vest on November 11, 2022 with the remaining options vesting over the subsequent three years in equal monthly installments.
Andrew Sims, as attorney-in-fact
2021-11-24